[An aortic insufficiency diagnosed under cabergoline].
We report the case of a restrictive aortic insufficiency diagnosed on a 53-year old woman while being treated by low dose of cabergoline for hyperprolactinemia. Such valves involvements had already been described with cabergoline and other dopamine agonists, drugs the patient was previously exposed to. However, chronology of events leads us to suspect cabergoline, although such effects had only been described with much higher doses. This case may recommend to perform echocardiograms upon patients treated by cabergoline, and probably such a caution may be enforced in patients previously exposed to other dopamine agonists. On another hand, the diagnostic of a restrictive valvulopathy may lead to suspect a iatrogenic origin including dopamine agonists.
Chagué
F
F
Centre d'Explorations Fonctionnelles, Hôpital du Bocage, Dijon Cedex, France. chaguefrederic@yahoo.fr
Belleville
I
I
Boujon
B
B
Petit
J-M
JM
D001022:Aortic Valve Insufficiency / Q000139:chemically induced*; D000077465:Cabergoline; D004873:Ergolines / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D008875:Middle Aged
D004873:Ergolines; D000077465:Cabergoline